Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-02-13 4:59 pm Purchase | 13G | ALYNLAM PHARMACEUTICALS INC ALNY | VANGUARD GROUP INC | 11,943,895 9.52% | 436,779 (+3.80%) | View |
| 2024-02-09 6:14 pm Sale | 13G | ALYNLAM PHARMACEUTICALS INC ALNY | Capital World Investors | 16,398,889 13.1% | -195,069 (-1.18%) | View |
| 2024-02-09 08:40 am Purchase | 13G | ALYNLAM PHARMACEUTICALS INC ALNY | WELLINGTON MANAGEMENT GROUP LLP | 7,252,907 5.78% | 991,265 (+15.83%) | View |
| 2024-02-09 08:35 am Sale | 13G | ALYNLAM PHARMACEUTICALS INC ALNY | FMR LLC | 10,342,397 8.239% | -3,200,428 (-23.63%) | View |
| 2024-01-29 12:18 pm Sale | 13G | ALYNLAM PHARMACEUTICALS INC ALNY | BAILLIE GIFFORD & CO | 6,967,097 5.55% | -2,440,774 (-25.94%) | View |
| 2024-01-26 5:25 pm Sale | 13G | ALYNLAM PHARMACEUTICALS INC ALNY | BlackRock Inc. BLK | 8,546,557 6.8% | -119,145 (-1.37%) | View |
| 2023-02-14 12:38 pm Sale | 13G | ALYNLAM PHARMACEUTICALS INC ALNY | PRICE T ROWE ASSOCIATES INC | 4,074,144 3.3% | -2,461,224 (-37.66%) | View |
| 2023-02-13 2:49 pm Purchase | 13G | ALYNLAM PHARMACEUTICALS INC ALNY | Capital World Investors | 16,593,958 13.5% | 3,777,181 (+29.47%) | View |
| 2023-02-09 11:07 am Purchase | 13G | ALYNLAM PHARMACEUTICALS INC ALNY | VANGUARD GROUP INC | 11,507,116 9.35% | 804,345 (+7.52%) | View |
| 2023-02-09 08:23 am Sale | 13G | ALYNLAM PHARMACEUTICALS INC ALNY | FMR LLC | 13,542,825 11.005% | -4,397,195 (-24.51%) | View |
| 2023-02-06 2:43 pm Sale | 13G | ALYNLAM PHARMACEUTICALS INC ALNY | WELLINGTON MANAGEMENT GROUP LLP | 6,261,642 5.09% | -578,179 (-8.45%) | View |
| 2023-01-31 1:58 pm Purchase | 13G | ALYNLAM PHARMACEUTICALS INC ALNY | BlackRock Inc. BLK | 8,665,702 7% | 994,300 (+12.96%) | View |
| 2023-01-19 12:08 pm Sale | 13G | ALYNLAM PHARMACEUTICALS INC ALNY | BAILLIE GIFFORD & CO | 9,407,871 7.65% | -1,208,880 (-11.39%) | View |
| 2022-09-09 12:30 pm Purchase | 13G | ALYNLAM PHARMACEUTICALS INC ALNY | Capital World Investors | 12,816,777 10.7% | 12,816,777 (New Position) | View |
| 2022-02-14 2:34 pm Purchase | 13G | ALYNLAM PHARMACEUTICALS INC ALNY | PRICE T ROWE ASSOCIATES INC | 6,535,368 5.4% | 2,859,543 (+77.79%) | View |
| 2022-02-09 3:24 pm Purchase | 13G | ALYNLAM PHARMACEUTICALS INC ALNY | VANGUARD GROUP INC | 10,702,771 8.95% | 176,347 (+1.68%) | View |
| 2022-02-09 09:09 am Purchase | 13G | ALYNLAM PHARMACEUTICALS INC ALNY | FMR LLC | 17,940,020 14.999% | 1,848,075 (+11.48%) | View |
| 2022-02-04 09:12 am Sale | 13G | ALYNLAM PHARMACEUTICALS INC ALNY | WELLINGTON MANAGEMENT GROUP LLP | 6,839,821 5.72% | -3,217,119 (-31.99%) | View |
| 2022-02-02 7:11 pm Sale | 13G | ALYNLAM PHARMACEUTICALS INC ALNY | BlackRock Inc. BLK | 7,671,402 6.4% | -1,052,318 (-12.06%) | View |
| 2022-01-18 07:06 am Purchase | 13G | ALYNLAM PHARMACEUTICALS INC ALNY | BAILLIE GIFFORD & CO | 10,616,751 8.88% | 1,484,329 (+16.25%) | View |